Latest Industry Insights

At the recent American Society for Mass Spectrometry conference in Baltimore, Technology Networks sat down with Dr. Nikhil Rao to learn more about Microscoop® Mint, an advanced sample preparation platform.

Dr. Tomek Czernuszewicz shares insights on the limitations of traditional delivery techniques and how Revvity is advancing in vivo imaging through AI-powered tools.

Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first clinical candidate from the ABX-01 program and how the platform could help shape the future of anti-infective therapy.

In this conversation, Joe Day speaks about the most exciting developments in AI-powered cancer research, the critical importance of diverse, high-quality data and what it takes to build patient trust.

Structure verification by NMR is a vital task in drug discovery but can be slow and subjective. This article explores how ASV transforms it into a scalable, consistent and reliable process.

Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve success rates.

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, CPS1, about how the product was created in just six months.

Novo Nordisk’s Transformational Prevention Unit (TPU) integrates AI, omics, and genomics to predict obesity risk and tailor interventions. By focusing on personalized solutions, TPU aims to prevent obesity and reduce the incidence of related diseases

Explore the clinical impact of accurate vitamin D measurement, how the cobas® Mass Spec solution enhances diagnostic precision and the broader role of clinical mass spectrometry in advancing personalized healthcare.

Chromatography-free mass spectrometry boosts throughput, cuts costs and simplifies drug monitoring – learn how Bruker and RECIPE are leading the way.